Individualized PsA Treatment With an IL-23i or a JAKi
Sponsored by AbbVie Medical Affairs + Health Impact
In Part 2 of our PsA management series, Saakshi Khattri, MD, and Lindsay Tom, PA-C, discuss tailoring treatment for patients with multidomain PsA and how IL-23i and JAKi data guide their decisions


